BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17984660)

  • 1. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population.
    Wang GL; Li Y; Staessen JA; Lu L; Wang JG
    J Hypertens; 2007 Dec; 25(12):2398-405. PubMed ID: 17984660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
    Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
    Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension.
    Fagard RH; Stolarz K; Kuznetsova T; Seidlerova J; Tikhonoff V; Grodzicki T; Nikitin Y; Filipovsky J; Peleska J; Casiglia E; Thijs L; Staessen JA; Kawecka-Jaszcz K
    J Hypertens; 2007 Nov; 25(11):2280-5. PubMed ID: 17921823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masked hypertension: different blood pressure measurement methodology and risk factors in a working population.
    Trudel X; Brisson C; Larocque B; Milot A
    J Hypertens; 2009 Aug; 27(8):1560-7. PubMed ID: 19444141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study.
    Asayama K; Sato A; Ohkubo T; Mimura A; Hayashi K; Kikuya M; Yasui D; Kanno A; Hara A; Hirose T; Obara T; Metoki H; Inoue R; Hoshi H; Satoh H; Imai Y
    Hypertens Res; 2009 Jun; 32(6):438-43. PubMed ID: 19390540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimada K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Grassi G; Sega R
    J Hypertens; 2009 Aug; 27(8):1672-8. PubMed ID: 19417688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study.
    Hara A; Ohkubo T; Kikuya M; Shintani Y; Obara T; Metoki H; Inoue R; Asayama K; Hashimoto T; Harasawa T; Aono Y; Otani H; Tanaka K; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
    J Hypertens; 2007 Feb; 25(2):321-7. PubMed ID: 17211239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
    Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
    Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
    Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study.
    Ugajin T; Hozawa A; Ohkubo T; Asayama K; Kikuya M; Obara T; Metoki H; Hoshi H; Hashimoto J; Totsune K; Satoh H; Tsuji I; Imai Y
    Arch Intern Med; 2005 Jul; 165(13):1541-6. PubMed ID: 16009871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth weight, hypertension and "white coat" hypertension: size at birth in relation to office and 24-h ambulatory blood pressure.
    Koupil I; Leon DA; Byberg L
    J Hum Hypertens; 2005 Aug; 19(8):635-42. PubMed ID: 15944722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study.
    Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M
    J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
    Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
    Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
    Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
    Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure and urinary cations in a Chinese population.
    Woo J; Lau E; Chan A; Cockram C; Swaminathan R
    J Hum Hypertens; 1992 Aug; 6(4):299-304. PubMed ID: 1433165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour autonomic nervous function in sustained and "white coat" hypertension.
    Pierdomenico SD; Bucci A; Costantini F; Lapenna D; Cuccurullo F; Mezzetti A
    Am Heart J; 2000 Oct; 140(4):672-7. PubMed ID: 11011344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.